Literature DB >> 10475153

Co-existence of osteogenesis imperfecta and hyperparathyroidism.

T Zimmermann-Belsing1, A M Lund, L Christensen, U Feldt-Rasmussen.   

Abstract

Osteogenesis imperfecta (OI) and hyperparathyroidism (HTP) are disorders affecting the skeletal system and calcium metabolism not evidently related to one another. We report a case in which both OI and HPT were present. Our female patient presented with hypercalcaemia (S-Ca2+ 1.59 mmol/l; normal range 1.15-1.30) and 4-gland parathyroid hyperplasia at 30 years of age. Since her first year she had fractures, blue sclera, hypermobile joints, short stature (height 1.51 m, weight 49.5 kg) but normal hearing, and dentiogenesis imperfecta (tooth disease caused by defective formation of dentin) was absent. This patient bears many similarities with the 5 patients reported previously but it is the only patient, to our knowledge, with OI and early onset of HPT (30 year old female). We have found the OI to be type 1. A minor improvement of the rate of bone turnover 10 months after parathyroidectomy indicates the HPT to be primary and suggests the OI type 1 and pHPT to be two different calcium metabolic diseases incidentally occurring in the same patient.

Entities:  

Mesh:

Year:  1999        PMID: 10475153     DOI: 10.1007/BF03343607

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  11 in total

1.  Parathyroid gland hemorrhage in perinatally lethal osteogenesis imperfecta.

Authors:  A S Knisely; M S Magid; J C Felix; D B Singer
Journal:  J Pediatr       Date:  1988-05       Impact factor: 4.406

Review 2.  Seminars in medicine of the Beth Israel Hospital, Boston. Mutations in collagen genes as a cause of connective-tissue diseases.

Authors:  D J Prockop
Journal:  N Engl J Med       Date:  1992-02-20       Impact factor: 91.245

Review 3.  Clinical variability in osteogenesis imperfecta-variable expressivity or genetic heterogeneity.

Authors:  D O Sillence; D L Rimoin; D M Danks
Journal:  Birth Defects Orig Artic Ser       Date:  1979

4.  Osteogenesis imperfecta and primary hyperparathyroidism.

Authors:  D P Nicholls; D C Anderson
Journal:  Ir J Med Sci       Date:  1980-08       Impact factor: 1.568

5.  Hypercalciuria in children severely affected with osteogenesis imperfecta.

Authors:  A Chines; D J Petersen; F W Schranck; M P Whyte
Journal:  J Pediatr       Date:  1991-07       Impact factor: 4.406

6.  Cysteine in the triple-helical domain of one allelic product of the alpha 1(I) gene of type I collagen produces a lethal form of osteogenesis imperfecta.

Authors:  B Steinmann; V H Rao; A Vogel; P Bruckner; R Gitzelmann; P H Byers
Journal:  J Biol Chem       Date:  1984-09-10       Impact factor: 5.157

7.  Genetic heterogeneity in osteogenesis imperfecta.

Authors:  D O Sillence; A Senn; D M Danks
Journal:  J Med Genet       Date:  1979-04       Impact factor: 6.318

8.  Molecular heterogeneity in osteogenesis imperfecta type I.

Authors:  M C Willing; C J Pruchno; P H Byers
Journal:  Am J Med Genet       Date:  1993-01-15

9.  Bone resorption assessed by immunoassay of urinary cross-linked collagen peptides in patients with osteogenesis imperfecta.

Authors:  R E Brenner; U Vetter; A M Bollen; M Mörike; D R Eyre
Journal:  J Bone Miner Res       Date:  1994-07       Impact factor: 6.741

10.  Diminished type I collagen synthesis and reduced alpha 1(I) collagen messenger RNA in cultured fibroblasts from patients with dominantly inherited (type I) osteogenesis imperfecta.

Authors:  D W Rowe; J R Shapiro; M Poirier; S Schlesinger
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.